IRIS
LOSA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.415
EU - Europa 3.956
NA - Nord America 3.618
SA - Sud America 934
AF - Africa 77
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.014
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.479
RU - Federazione Russa 2.373
SG - Singapore 1.596
CN - Cina 1.421
BR - Brasile 774
HK - Hong Kong 568
SE - Svezia 495
VN - Vietnam 367
IT - Italia 360
FR - Francia 203
DE - Germania 127
GB - Regno Unito 113
IN - India 103
BD - Bangladesh 93
AR - Argentina 74
IE - Irlanda 68
CA - Canada 61
MX - Messico 50
PL - Polonia 37
AT - Austria 34
JP - Giappone 34
FI - Finlandia 33
ID - Indonesia 32
NL - Olanda 26
TR - Turchia 24
ZA - Sudafrica 23
EC - Ecuador 22
IQ - Iraq 20
EG - Egitto 17
MA - Marocco 17
VE - Venezuela 17
ES - Italia 16
MY - Malesia 16
PH - Filippine 15
SA - Arabia Saudita 15
UA - Ucraina 14
UZ - Uzbekistan 14
PK - Pakistan 13
CL - Cile 12
CO - Colombia 12
LT - Lituania 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
KZ - Kazakistan 8
MD - Moldavia 8
AU - Australia 7
IR - Iran 7
PE - Perù 7
AZ - Azerbaigian 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
JM - Giamaica 5
LB - Libano 5
NP - Nepal 5
TH - Thailandia 5
XK - ???statistics.table.value.countryCode.XK??? 5
CR - Costa Rica 4
HU - Ungheria 4
IL - Israele 4
JO - Giordania 4
KE - Kenya 4
PS - Palestinian Territory 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
CY - Cipro 3
CZ - Repubblica Ceca 3
GR - Grecia 3
HN - Honduras 3
KG - Kirghizistan 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
KR - Corea 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
MT - Malta 2
NG - Nigeria 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
IS - Islanda 1
Totale 13.001
Salva come PNG Salva come JPEG
Città #
Singapore 727
Moscow 586
Hong Kong 559
Ashburn 445
San Jose 418
Dallas 380
Shanghai 286
Council Bluffs 257
The Dalles 230
North Charleston 204
Hefei 202
Lawrence 168
Princeton 168
Lauterbourg 165
Beijing 162
New York 139
Ho Chi Minh City 129
Milan 93
Hanoi 84
Los Angeles 75
São Paulo 73
Dublin 68
Santa Clara 59
Munich 50
Las Vegas 46
Orem 35
Rome 34
Warsaw 32
Tokyo 29
Chennai 26
Haiphong 26
Boardman 25
Rio de Janeiro 25
Seattle 25
Waynesboro 24
Nuremberg 23
Washington 23
London 22
Chicago 21
Manchester 21
Boston 19
Guangzhou 18
Helsinki 18
Toronto 18
Atlanta 17
Brooklyn 17
Curitiba 16
Mexico City 16
Phoenix 16
Poplar 16
Belo Horizonte 15
Frankfurt am Main 15
Bologna 14
Brasília 14
Houston 14
Montreal 14
Stockholm 14
Turku 14
Amsterdam 13
Cairo 13
Campinas 13
Columbus 13
Pune 13
San Francisco 13
Tashkent 13
Vienna 13
Denver 12
Mumbai 12
Johannesburg 11
Da Nang 10
Porto Alegre 10
Shenzhen 10
Buffalo 9
Casablanca 9
Cesano Boscone 9
Hải Dương 9
Kuala Lumpur 9
Querétaro 9
Riyadh 9
Ankara 8
Barnet 8
Charlottesville 8
Dhaka 8
Guarulhos 8
Guayaquil 8
Naples 8
Ribeirão Preto 8
Salvador 8
Santiago 8
Biên Hòa 7
Caracas 7
Contagem 7
Hangzhou 7
Hanover 7
Paris 7
Tianjin 7
Turin 7
Buenos Aires 6
Goiânia 6
Jakarta 6
Totale 6.835
Salva come PNG Salva come JPEG
Nome #
Cushing's disease due to double pituitary ACTH-secreting adenomas: The first case report 821
Pituitary Surgery 173
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update 138
Asymptomatic Thyrotropin-secreting Pituitary Macroadenoma in a Thirteen Year-old Girl: Successful First-line Treatment with Somatostatin Analogues 131
Craniopharyngioma 131
Acromegaly associated with a granular cell tumor of the neurohypophysis: a clinical and histological study - Case report 130
Gamma knife radiosurgery in patients with Nelson’s syndrome 123
Benign and Malignant Tumors of the Pituitary Gland 117
A non-functioning pituitary adenoma initially mimicking a microprolactinoma: The case for long-term follow-up of patients with mild hyperprolactinemia? 113
Craniopharyngiomas 111
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature 110
A Multicenter, Propensity Score–Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas 107
Novel approach to bone comorbidity in resistant acromegaly 107
High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly 105
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 104
Acromegaly: surgical results and prognosis. 102
Gamma knife radiosurgery for pituitary tumors: A systematic review and meta‐analysis 102
Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity 97
Acromegaly is associated with increased cancer risk: A survey in Italy 96
Bacterial endotoxin (Lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the Toll-like receptor 4 96
High prevalence of adrenal cortical adenomas in patients with cerebral meningiomas 95
Intranasal oxytocin as a treatment for obesity: safety and efficacy 95
AZA-Deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors 94
Crooke Cell Adenoma Confers Poorer Endocrinological Outcomes Compared with Corticotroph Adenoma: Results of a Multicenter, International Analysis 92
Craniopharyngioma in Pediatrics and Adults 89
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma 89
Normal insulin-like growth factor 1 during somatostatin receptor ligand treatment predicts surgical cure in acromegaly 89
Primary sellar melanocytoma: report of two cases treated at the same institution and their long-term outcome 87
A conformational switch controlling the toxicity of the prion protein 85
Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action 85
Bilateral inferior petrosal sinus sampling in adrenocorticotropin-dependent hypercortisolism: always, never, or sometimes? 85
The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective 84
Pituitary radiotherapy for Cushing's disease 83
Bone and body composition analyses by DXA in adults with GH deficiency: effects of long-term replacement therapy 83
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 82
Erratum: Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors (Radiotherapy and Oncology 99 (2011) (23-28)) 81
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS) 81
Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study 80
The open sella technique for surgical treatment of pituitary macroadenomas: Safety and efficacy in a large clinical series 79
Widened transnasal surgical approach for removal of huge, forward-spreading pituitary neoplasms 77
Microsurgical therapy of pituitary adenomas 77
The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: An international multicenter report 76
Repeat gamma knife radiosurgery for recurrent pituitary adenomas. 76
Complications of transsphenoidal surgery in patients with pituitary adenoma: experience at a single centre 75
Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing 75
Letter to the Editor. Management of residual nonfunctioning pituitary adenoma: watchful waiting or adjuvant treatment? 72
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients 72
Treatment of empty sella associated with visual impairment: a systematic review of chiasmapexy techniques 71
Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly 71
Role of radiosurgery in the treatment of Cushing's disease 70
Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels RID B-6543-2008 70
Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series 70
Asymptomatic internal carotid artery occlusion after gamma knife radiosurgery for pituitary adenoma: Report of two cases and review of the literature 70
D3-Growth hormone receptor polymorphism in acromegaly: Effects on metabolic phenotype 70
Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas RID B-6543-2008 69
Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease 69
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement 69
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. 67
Metastatic prostatic adenocarcinoma presenting as a pituitary mass: Shrinkage of the lesion and clinical improvement with medical treatment 66
The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas 65
Combined insulin resistance of glucose and protein metabolism in acromegaly 65
Endocrine inactive and gonadotroph adenomas: diagnosis and management 65
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer 65
Increased insulin-stimulated endothelin-1 release is a distinct vascular phenotype distinguishing Cushing's disease from metabolic syndrome 65
Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors 64
Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas. 64
Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease. 64
Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism 63
Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors - Comparison between micro- and macroadenomas 63
Surgical treatment of prolactin-secreting pituitary adenomas: Early results and long-term outcome 63
First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group 63
Proliferation index of nonfunctioning pituitary adenomas: Correlations with clinical characteristics and long-term follow-up results 62
Frequency, pattern, and outcome of recurrences after gamma knife radiosurgery for pituitary adenomas 62
Combined insulin resistance of glucose and protein metabolism in acromegaly. 62
Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma 62
Pros and cons in endocrine practice: pre-surgical treatment with somatostatin analogues in acromegaly 62
Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [F-18]fluoro-ethyl-spiperone RID C-6773-2008 61
Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors 61
Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency 61
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 61
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients 61
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 60
Surgery followed by gamma knife radiosurgery for treatment of acromegaly 60
Longitudinal splitting of optic pathways by non-functioning pituitary macroadenoma: report of two cases. 60
Solitary clival plasmocytomas: Misleading clinical and radiological features of a rare pathology with a specific biological behaviour. 60
Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas 60
Predictors of morbidity and mortality in acromegaly: An Italian survey 59
Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS) 59
Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations 59
Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas 58
Intrasellar paraganglioma: a case report and review of the literature 58
Non-functioning pituitary adenoma database: A useful resource to improve the clinical management of pituitary tumors 58
Primary sellar melanocytoma: pathological, clinical and treatment review 58
Surgical approach to craniopharyngiomas: transcranial routes 58
Surgical therapy of pituitary adenomas 57
Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy 57
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells 57
Responsiveness of gonadotropins to TRH in patients with nonfunctioning pituitary adenomas: correlation with immunoistochemical results 56
Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas 56
High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy 56
Totale 8.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.779
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202286 0 0 0 49 7 1 13 3 1 2 1 9
2022/2023939 364 169 87 39 10 100 70 74 20 2 1 3
2023/2024491 18 5 40 37 46 140 6 39 3 17 26 114
2024/20252.492 359 62 15 77 68 234 371 163 418 312 187 226
2025/20269.086 602 786 734 1.122 557 790 820 563 2.155 456 288 213
Totale 13.262